• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测严重发热伴血小板减少综合征患者死亡率的列线图。

A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome.

机构信息

Department of Transfusion Medicine, Weihai Municipal Hospital, No. 70 of Heping Road, WeihaiShandong, 264200, China.

出版信息

Sci Rep. 2024 May 9;14(1):10627. doi: 10.1038/s41598-024-60923-9.

DOI:10.1038/s41598-024-60923-9
PMID:38724615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081946/
Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an acute infectious disease caused by a novel Bunyavirus infection with low population immunity and high mortality rate. Lacking specific therapies, the treatment measures vary with the severity of the disease, therefore, a case control study involved 394 SFTS patients was taken to determine risk factors for mortality. Comparative clinical data from the first 24 h after admission was collected through the electronic medical record system. Independent risk factors for death of SFTS were identified through univariate and multivariate binary logistic regression analyses. The results of the logistic regression were visualized using a nomogram which was created by downloading RMS package in the R program. In our study, four independent mortality risk factors were identified: advanced age(mean 70.45 ± 7.76 years), MODS, elevated APTT, and D-dimer. The AUC of the nomogram was 0.873 (0.832, 0.915), and the model passes the calibration test namely Unreliability test with P = 0.958, showing that the model's predictive ability is excellent. The nomogram to determine the risk of death in SFTS efficiently provide a basis for clinical decision-making for treatment.

摘要

严重发热伴血小板减少综合征(SFTS)是一种由新型布尼亚病毒感染引起的急性传染病,人群免疫力低,死亡率高。由于缺乏特效治疗方法,治疗措施随疾病严重程度而异,因此对 394 例 SFTS 患者进行了病例对照研究,以确定死亡率的危险因素。通过电子病历系统收集入院后 24 小时内的比较临床数据。通过单因素和多因素二元逻辑回归分析确定 SFTS 死亡的独立危险因素。逻辑回归的结果使用通过 R 程序下载 RMS 包创建的列线图可视化。在我们的研究中,确定了四个独立的死亡风险因素:高龄(平均 70.45±7.76 岁)、MODS、APTT 升高和 D-二聚体。列线图的 AUC 为 0.873(0.832,0.915),模型通过校准测试,即不可靠性测试,P=0.958,表明模型的预测能力优异。该列线图可有效确定 SFTS 患者死亡风险,为临床治疗决策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/cf590f1b922b/41598_2024_60923_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/a853fe062d37/41598_2024_60923_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/3ee7033d6495/41598_2024_60923_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/1498ac649af9/41598_2024_60923_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/bdddb2451325/41598_2024_60923_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/cf590f1b922b/41598_2024_60923_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/a853fe062d37/41598_2024_60923_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/3ee7033d6495/41598_2024_60923_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/1498ac649af9/41598_2024_60923_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/bdddb2451325/41598_2024_60923_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cf/11081946/cf590f1b922b/41598_2024_60923_Fig5_HTML.jpg

相似文献

1
A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome.用于预测严重发热伴血小板减少综合征患者死亡率的列线图。
Sci Rep. 2024 May 9;14(1):10627. doi: 10.1038/s41598-024-60923-9.
2
A nomogram including admission serum glycated albumin/albumin ratio to predict mortality in patients with severe fever with thrombocytopenia syndrome.包含入院时糖化血清白蛋白/白蛋白比值的列线图预测重症发热伴血小板减少综合征患者的死亡率。
BMC Infect Dis. 2024 Aug 23;24(1):858. doi: 10.1186/s12879-024-09752-9.
3
Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission.构建并验证了一个基于 Lasso-Logistic 回归的动态列线图,用于预测入院时严重发热伴血小板减少综合征患者的严重程度。
BMC Infect Dis. 2024 Sep 18;24(1):996. doi: 10.1186/s12879-024-09867-z.
4
Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients.建立并验证一个临床风险评分模型,以预测发热伴血小板减少综合征住院患者的死亡风险。
BMC Infect Dis. 2024 Sep 13;24(1):975. doi: 10.1186/s12879-024-09898-6.
5
Novel nomograms to predict risk and prognosis in hospitalized patients with severe fever with thrombocytopenia syndrome.预测发热伴血小板减少综合征住院患者风险和预后的新型列线图
Front Med (Lausanne). 2023 Dec 1;10:1321490. doi: 10.3389/fmed.2023.1321490. eCollection 2023.
6
Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A single-center cohort study.PLNA 评分预测急性期发热伴血小板减少综合征患者细胞因子风暴的开发和验证:一项单中心队列研究。
Int Immunopharmacol. 2024 Jul 30;136:112288. doi: 10.1016/j.intimp.2024.112288. Epub 2024 May 31.
7
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
8
A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China.一种用于预测早期严重发热伴血小板减少综合征患者死亡率的列线图:中国多中心研究。
PLoS Negl Trop Dis. 2019 Nov 25;13(11):e0007829. doi: 10.1371/journal.pntd.0007829. eCollection 2019 Nov.
9
High C-reactive protein to lymphocyte ratio predicts mortality outcomes of patients with severe fever with thrombocytopenia syndrome: A multicenter study in China.高C反应蛋白与淋巴细胞比值可预测发热伴血小板减少综合征患者的死亡结局:一项中国多中心研究
J Med Virol. 2023 Feb;95(2):e28546. doi: 10.1002/jmv.28546.
10
Fibrinogen-to-prealbumin and C-reactive protein-to-prealbumin ratios as prognostic indicators in severe fever with thrombocytopenia syndrome.纤维蛋白原/前白蛋白比值和 C 反应蛋白/前白蛋白比值作为重症发热伴血小板减少综合征的预后指标。
Front Cell Infect Microbiol. 2024 Jun 10;14:1397789. doi: 10.3389/fcimb.2024.1397789. eCollection 2024.

引用本文的文献

1
Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.抑制巨噬细胞中细胞色素P450 1B1(CYP1B1)的表达可降低2型糖尿病合并肺结核患者的炎症反应。
Front Endocrinol (Lausanne). 2025 Aug 21;16:1617292. doi: 10.3389/fendo.2025.1617292. eCollection 2025.
2
Alarming implications: severe fever with thrombocytopenia syndrome and its biological vectors in the context of climate change.警示意义:气候变化背景下的严重发热伴血小板减少综合征及其生物媒介
Front Microbiol. 2025 Jul 25;16:1544427. doi: 10.3389/fmicb.2025.1544427. eCollection 2025.
3

本文引用的文献

1
Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome.发热伴血小板减少综合征的流行病学、临床特征及治疗
Infect Med (Beijing). 2022 Jan 1;1(1):40-49. doi: 10.1016/j.imj.2021.10.001. eCollection 2022 Mar.
2
Transmission and mortality risk assessment of severe fever with thrombocytopenia syndrome in China: results from 11-years' study.中国发热伴血小板减少综合征的传播和病死率评估:11 年研究结果。
Infect Dis Poverty. 2022 Sep 4;11(1):93. doi: 10.1186/s40249-022-01017-4.
3
Human-to-human transmission of severe fever with thrombocytopenia syndrome virus through potential ocular exposure to infectious blood.
Prediction of Mortality by Clinical Laboratory Parameters in Severe Fever with Thrombocytopenia Syndrome: A Meta-Analysis.
通过临床实验室参数预测发热伴血小板减少综合征患者的死亡率:一项Meta分析
Trop Med Infect Dis. 2025 Jul 9;10(7):193. doi: 10.3390/tropicalmed10070193.
4
Malignant epithelial cell marker-driven risk signature enables precise stratification in esophageal cancer.恶性上皮细胞标志物驱动的风险特征可实现食管癌的精准分层。
Front Immunol. 2025 May 27;16:1610991. doi: 10.3389/fimmu.2025.1610991. eCollection 2025.
5
Integration of Bioinformatics and Machine Learning Strategies Identifies Ferroptosis and Immune Infiltration Signatures in Peri-Implantitis.生物信息学与机器学习策略的整合识别种植体周围炎中的铁死亡和免疫浸润特征
Int J Mol Sci. 2025 May 1;26(9):4306. doi: 10.3390/ijms26094306.
6
Early therapy contributes to the normalization of platelet in patients with severe fever with thrombocytopenia syndrome during the convalescent phase.早期治疗有助于重症发热伴血小板减少综合征患者在恢复期血小板恢复正常。
PLoS Negl Trop Dis. 2025 Jan 13;19(1):e0012793. doi: 10.1371/journal.pntd.0012793. eCollection 2025 Jan.
7
Identification of early prognostic biomarkers in Severe Fever with Thrombocytopenia Syndrome using machine learning algorithms.使用机器学习算法识别严重发热伴血小板减少综合征的早期预后生物标志物。
Ann Med. 2025 Dec;57(1):2451184. doi: 10.1080/07853890.2025.2451184. Epub 2025 Jan 13.
8
Development and validation of a clinical and laboratory-based nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome.建立并验证一种基于临床和实验室数据的列线图模型以预测发热伴血小板减少综合征重症患者的病死率。
BMC Infect Dis. 2024 Oct 25;24(1):1206. doi: 10.1186/s12879-024-10106-8.
9
Red Blood Cell Distribution Width Predicts Mortality in Hospitalized Patients with Severe Fever with Thrombocytopenia Syndrome.红细胞分布宽度可预测住院严重发热伴血小板减少综合征患者的死亡率。
J Inflamm Res. 2024 Jul 22;17:4895-4904. doi: 10.2147/JIR.S468388. eCollection 2024.
通过潜在的眼部接触感染血液导致严重发热伴血小板减少综合征病毒在人与人之间传播。
Int J Infect Dis. 2022 Oct;123:80-83. doi: 10.1016/j.ijid.2022.08.008. Epub 2022 Aug 18.
4
Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).严重发热伴血小板减少综合征免疫发病机制概述(综述)。
Int J Mol Med. 2022 Sep;50(3). doi: 10.3892/ijmm.2022.5174. Epub 2022 Jul 20.
5
A ten-year assessment of the epidemiological features and fatal risk factors of hospitalised severe fever with thrombocytopenia syndrome in Eastern China.中国东部地区住院严重发热伴血小板减少综合征的流行病学特征和致死危险因素十年评估
Epidemiol Infect. 2022 Jun 21;150:e131. doi: 10.1017/S0950268822001108.
6
Viral Load as a Factor Affecting the Fatality of Patients Suffering from Severe Fever with Thrombocytopenia Syndrome.病毒载量作为影响重症发热伴血小板减少综合征患者病死率的一个因素。
Viruses. 2022 Apr 23;14(5):881. doi: 10.3390/v14050881.
7
Clinical symptoms associated with fatality of severe fever with thrombocytopenia syndrome: A systematic review and meta-analysis.与发热伴血小板减少综合征重症病例死亡相关的临床症状:系统评价和荟萃分析。
Acta Trop. 2022 Aug;232:106481. doi: 10.1016/j.actatropica.2022.106481. Epub 2022 Apr 21.
8
Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea.韩国严重发热伴血小板减少综合征患者死亡相关的病毒和免疫因素。
Viruses. 2021 Nov 23;13(12):2351. doi: 10.3390/v13122351.
9
Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality.严重发热伴血小板减少综合征的临床特征及死亡危险因素分析。
BMC Infect Dis. 2021 Dec 14;21(1):1253. doi: 10.1186/s12879-021-06946-3.
10
Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study.严重发热伴血小板减少综合征相关脑炎/脑病的临床特征:一项回顾性研究。
BMC Infect Dis. 2021 Sep 3;21(1):904. doi: 10.1186/s12879-021-06627-1.